Azido­[1,1′‐bis­(di­phenyl­phosphino)­ferrocene](penta­methyl­cyclo­penta­dienyl)­rhodium(III) hexa­fluoro­phosphate

In the title compound, azido‐2κN‐bis­[μ‐(1η⁵:2κP)‐di­phenyl­phosphino­cyclo­penta­dienyl][2(η⁵)‐penta­methyl­cyclo­penta­di­enyl]­iron(III)­rhodium(III) hexa­fluoro­phosphate, [{Rh(C₁₀H₁₅)(N₃)}{Fe(μ‐C₁₇H₁₄P)₂}]PF₆ or [FeRh(C₁₀H₁₅)(μ‐C₁₇H₁₄P)₂(N₃)]PF₆, the coordination sphere of Rh^III can be described as pseudo‐tetrahedral, composed of two P atoms from a 1,1′‐bis­(di­phenyl­phosphino)­ferrocene (dppf) ligand, an azido N atom and the centroid of the ring of a C₅Me₅ (Cp*) ligand. The two cyclo­penta­dienyl rings in the dppf moiety adopt an eclipsed conformation. The Rh⋯Fe distance is 4.340 (2) Å.     

The first di‐μ‐hydro­xo‐bridged binuclear copper complex containing a bis‐guanidine ligand

The present structure determination of di‐μ‐hydroxo‐bis{[N,N′‐bis­(dipiperidino­methyl­ene)­propane‐1,3‐di­amine‐κ²N,N′]copper(II)} bis­(hexa­fluoro­phosphate), [Cu₂(OH)₂(C₂₅H₄₆N₆)₂](PF₆)₂, is the first to crystallographically characterize a Cu₂(μ‐OH)₂ complex with a bidentate guanidine ligand. The cation lies on a crystallographic inversion centre and shows planar fourfold coordination of the copper centres. The Cu₂(μ‐OH)₂ species can be distinguished from Cu₂(μ‐O)₂ by the Cu—O bond lengths. The packing is determined by strong intermolecular anion–cation hydrogen bonds.     

Two N,N‐dimethylbiguanidium salts displaying double hydrogen bonds to the counter‐ions

The crystal structures of N,N‐di­methyl­biguanidium oxalate monohydrate, C₄H₁₃N₅²⁺·C₂O₄²⁻·H₂O, (I), and N,N‐di­methyl­biguanidium sulfate monohydrate, C₄H₁₃N₅²⁺·SO₄²⁻·H₂O, (II), show that both compounds contain the same N,N‐di­methyl­biguanidium dication. In (I), two independent oxalate ions lie about inversion centres. Strong double hydrogen bonds, with D⋯A distances of 2.658 (2) and 2.830 (3) Å in (I), and 2.722 (3) and 2.815 (3) Å in (II), are present between N atoms of the N,N‐di­methyl­biguanidium moieties and either the carboxyl­ate group of the oxalate anion or the sulfate anion.     

A structural hierarchy in the hydrogen‐bonded adduct N,N′‐di­methyl­piperazine–tartaric acid–water (1/2/2): an N‐component N‐dimensional structure (N = 3) with substructures having N = 1 and 2

In the hydrated adduct N,N′‐di­methyl­piperazine‐1,4‐diium bis(3‐carboxy‐2,3‐di­hydroxy­propanoate) dihydrate, [MeNH(CH₂CH₂)₂NHMe]²⁺·2(C₄H₅O₆)^?·2H₂O or C₆H₁₆N₂²⁺·2C₄H₅O₆^?·2H₂O, formed between racemic tartaric acid and N,N′‐di­methyl­piperazine (triclinic P, Z′ = 0.5), the cations lie across centres of inversion. The anions alone form chains, and anions and water mol­ecules together form sheets; the sheets are linked by the cations to form a pillared‐layer framework. The supramolecular architecture thus takes the form of a family of N‐dimensional N‐component structures having N = 1, 2 or 3.     

(η3‐Allyl‐2κ3C)(chloro‐1κCl)(μ‐N,N′‐diethyldithioxamidato‐1:2κ4S,S′:N,N′)[diphenyl(2‐pyridyl)phosphine‐1κP]palladium(II)platinum(II) chloroform solvate

The title compound, [PdPtCl(C₃H₅)(C₆H₁₀N₂S₂)(C₁₇H₁₄NP)]·CHCl₃, was obtained by deprotonation of the initial platinum(II) complex of the di­thio­xamide and subsequent reaction with [Pd(η³‐C₃H₅)(μ‐Cl)]₂. Both metal atoms exhibit a square‐planar coordination geometry, with the two planes forming a dihedral angle of 21.7 (2)°. The di­thio­xamide bis‐chelating bridge is flat.     

Ranitidine hydro­chloride,a polymorphic crystal form

In the title compound, di­methyl­({5‐[2‐(1‐methyl­amino‐2‐nitro­eth­enyl­amino)­ethyl­thio­methyl]‐2‐furyl}­methyl)­ammon­ium chloride, C₁₃H₂₃N₄O₃S⁺·­Cl^?, protonation occurs at the di­methyl­amino N atom. The ranitidine mol­ecule adopts an eclipsed conformation. Bond lengths indicate extensive electron delocalization in the N,N′‐di­methyl‐2‐nitro‐1,1‐ethenedi­amine system of the mol­ecule. The nitro and methyl­amino groups are trans across the side chain C=C double bond, while the ethyl­amino and nitro groups are cis. The Cl^? ions link mol­ecules through hydrogen bonds.     

[Hydroxy(aryl)methylene]diphos­phonic acids,a class of drugs in bone pathology treatments,crystallize as head‐to‐head dimers

Two [hydroxy­(aryl)­methyl­ene]­di­phospho­nic acids have been crystallized as dimers. The first compound, [hydroxy­(phenyl)­methyl­ene]­di­phospho­nic acid monohydrate, C₇H₁₀O₇P₂·H₂O, crystallizes in the non‐centrosymmetric space group P2₁, with the two enantiomers related by a non‐crystallographic centre of inversion, while the second compound, [hydroxy(4‐nitro­phenyl)­methyl­ene]­di­phospho­nic acid tetra­hydro­furan disolvate, C₇H₉NO₉P₂·2C₄H₈O, crystallizes in the centrosymmetric space group P2₁/c and uses the centre of symmetry to form the same dimer.     

2,4‐Di­nitro­phenyl­hydrazones of 2,4‐di­hydroxy­benz­aldehyde, 2,4‐di­hydroxy­aceto­phenone and 2,4‐di­hydroxy­benzo­phenone

In 2,4‐di­hydroxy­benz­aldehyde 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­form­amide solvate {or 4‐[(2,4‐di­nitro­phenyl)­hydrazono­methyl]­benzene‐1,3‐diol N,N‐di­methyl­form­amide solvate}, C₁₃H₁₀N₄O₆·C₃H₇NO, (X), 2,4‐di­hydroxy­aceto­phenone 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­form­am­ide solvate (or 4‐{1‐[(2,4‐di­nitro­phenyl)hydrazono]ethyl}benzene‐1,3‐diol N,N‐di­methyl­form­amide solvate), C₁₄H₁₂N₄O₆·C₃H₇NO, (XI), and 2,4‐di­hydroxy­benzo­phenone 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­acet­amide solvate (or 4‐­{[(2,4‐di­nitro­phenyl)hydrazono]phenyl­methyl}benzene‐1,3‐diol N,N‐di­methyl­acet­amide solvate), C₁₉H₁₄N₄O₆·C₄H₉NO, (XII), the molecules all lack a center of symmetry, crystallize in centrosymmetric space groups and have been observed to exhibit non‐linear optical activity. In each case, the hydrazone skeleton is fairly planar, facilitated by the presence of two intramolecular hydrogen bonds and some partial N—N double‐bond character. Each molecule is hydrogen bonded to one solvent mol­ecule.     

Charge‐transfer complexes of 4‐(di­methyl­amino)­pyridine with 2,4‐, 3,4‐ and 3,5‐di­nitro­benzoic acid

In the three title crystal structures 4‐(di­methyl­amino)­pyridinium 2,4‐di­nitro­benzoate, (I), 4‐(di­methyl­amino)­pyri­dinium 3,4‐di­nitro­benzo­ate, (II), and 4‐(di­methyl­amino)pyri­din­ium 3,5‐di­nitro­benzo­ate, (III), all C₇H₁₁N₂⁺·C₇H₃N₂O₆^?, the ions are connected by an N—H?O hydrogen bond. Dihedral angles between the pyridine and phenyl rings are 69.9 (1), 26.7 (1) and 56.2 (1)° in (I), (II) and (III), respectively. Donor–acceptor π–π stacking is observed in (II) and (III), but not in (I).     

The trans influence of the pyridine ligand on ruthenium(II)–porphyrin–carbene complexes

In the two ruthenium(II)–porphyrin–carbene complexes ­(di­benzoyl­carbenyl‐κC)(pyridine‐κN)(5,10,15,20‐tetra‐p‐tolyl­porphyrinato‐κ⁴N)­ruthenium(II), [Ru(C₁₅H₁₀O₂)(C₅H₅N)(C₄₈H₃₆N₄)], (I), and (pyridine‐κN)(5,10,15,20‐tetra‐p‐tolyl­porphyrinato‐κ⁴N)[bis(3‐tri­fluoro­methyl­phenyl)­carbenyl‐κC]­ruthenium(II), [Ru(C₁₅H₈F₆)(C₅H₅N)(C₄₈H₃₆N₄)], (II), the pyridine ligand coordinates to the octahedral Ru atom trans with respect to the carbene ligand. The C(carbene)—Ru—N(pyridine) bonds in (I) coincide with a crystallographic twofold axis. The Ru—C bond lengths of 1.877 (8) and 1.868 (3) Å in (I) and (II), respectively, are slightly longer than those of other ruthenium(II)–porphyrin–carbene complexes, owing to the trans influence of the pyridine ligands.     

Layered zincoarsenate templated by N,N,N′,N′‐tetra­methyl­ethyl­ene‐di­amine mol­ecules

The title compound, N,N,N′,N′‐tetra­methyl­ethyl­enedi­ammon­ium di­aqua­(arsenate)­(hydrogen arsenate)­dizinc(II), (C₆H₁₈N₂)_0.5[Zn₂(AsO₄)(HAsO₄)(H₂O)₂], is a new zincoarsenate obtained by hydro­thermal synthesis. The structure consists of infinite two‐dimensional anionic layers alternating with planes containing centrosymmetric organic diprotonated template N,N,N′,N′‐tetra­methyl­ethyl­enedi­ammonium cations, [H₃N­C₆H₁₂NH₃]²⁺. The latter are interconnected to the framework through hydrogen bonds.     

Packing considerations of bis‐dimedone derivatives

We have determined the crystal structures of 2,2′‐(4‐fluoro­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇FO₄, (I), 2,2′‐(4‐chloro­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐dimethyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇ClO₄, (II), 2,2′‐(4‐hydroxy­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₈O₅, (III), 2,2′‐(4‐methyl­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₄, (IV), 2,2′‐(4‐methoxy­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₅, (V), and 2,2′‐(4‐N,N′‐di­methyl­amino­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₅H₃₃NO₄, (VI). Structures (III) to (VI) of these bis‐dimedone derivatives show nearly the same packing pattern irrespective of the different substituent in the para position of the aromatic ring. However, (II) does not fit into this scheme, although the Cl atom is a substituent not too different from the others. The different packing of the fluoro compound, (I), can be explained by the fact that it crystallizes with two mol­ecules in the asymmetric unit, which show a different conformation of the dimedone ring. On the other hand, (I) shows a similar packing pattern to bis(2‐hydroxy‐4,4‐di­methyl‐6‐oxo‐1‐cyclo­hexenyl)­phenyl­methane, a compound containing an aromatic ring without any substituent and with Z′ = 2.     

Tri­azido­cobalt(III) complexes with tridentate amine ligands

The title compounds, [N‐(2‐amino­ethyl)‐1,3‐propane­di­amine‐κ³N]­tri­azido­cobalt(III), [Co(N₃)₃(C₅H₁₅N₃)], [N‐(2‐amino­ethyl)‐N‐methyl‐1,3‐propane­di­amine‐κ³N]­tri­azido­cobalt(III), [Co(N₃)₃(C₆H₁₇N₃)], [N‐(2‐amino­propyl)‐1,3‐pro­pane­di­am­ine‐κ³N]­tri­azido­cobalt(III), [Co(N₃)₃(C₆H₁₇N₃)], and [N‐(2‐amino­propyl)‐N‐methyl‐1,3‐pro­pane­di­am­ine‐κ³N]triazidocobalt(III), [Co(N₃)₃­(C₇­H₁₉­N₃)], each consist of a Co^III atom, three azide ligands in a meridional configuration and a tridentate amine ligand, namely aepn [N‐(2‐amino­ethyl)‐1,3‐propane­di­amine] or dpt [N‐(3‐amino­propyl)‐1,3‐pro­pane­di­amine], or their N‐methyl­­ated analogs.     

Di­chloro­bis(3,5‐di­methyl­pyrazole‐N2)methyl­phenyl­tin(IV)

The title compound, [SnCl₂(CH₃)(C₆H₅)(C₅H₈N₂)₂], was obtained by reaction of di­chloro­methyl­phenyl­tin(IV) and 3,5‐di­methyl­pyrazole (dmpz) in chloro­form, and was recrystallized from acetone. The structure consists of octahedral all‐trans [SnMePhCl₂(dmpz)₂] mol­ecules, with the Sn atom coordinated to two C [Sn—C 2.127 (5) and 2.135 (4) Å], two Cl [Sn—Cl 2.5753 (8) Å] and two N atoms [Sn—N 2.357 (3) Å]. The dmpz ligands, bound to the metal through their unprotonated N atoms, form weak intra‐ and intermolecular hydrogen bonds with the Cl ligands via their NH groups, giving rise to a polymeric chain along the c axis.     

Disappearance of intramolecular stacking due to one‐atom movement or increment of a `propyl­ene linker' in pyrazolo­[3,4‐d]­pyrimidine‐based ­flexible models

In the crystal structures of 4,6‐di­methyl­thio‐1‐[3‐(4,6‐di­methyl­thio‐2H‐pyra­zolo­[3,4‐d]­py­rimi­din‐2‐yl)­propyl]‐1H‐py­ra­­zolo­[3,4‐d]­py­rimi­dine, C₁₇H₂₀N₈S₄, and 1‐[4‐(4‐meth­oxy‐6‐methyl­thio‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐1‐yl)­butyl]‐5‐meth­yl‐6‐methyl­thio‐4,5‐di­hydro‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐4‐one, C₁₈H₂₂N₈O₂S₂, only intermolecular stacking due to aromatic π–π interactions between pyrazolo­[3,4‐d]­pyrimidinerings is present.     

{2,6‐Bis­[(di­methyl­amino)­methyl]pyridine‐κ3N}(2,2‐methyl­enediphenolato‐κ2O,O′)­dioxouranium(VI) acetone solvate

In the title compound, [UO₂(C₁₃H₁₀O₂)(C₁₁H₁₉N₃)]·C₃H₆O, the U atom is in a pentagonal–bipyramidal environment, with the three N atoms of the 2,6‐bis­[(di­methyl­amino)­methyl]­pyridine ligand and the two O atoms of the dianionic 2,2′‐methyl­ene­diphenolate ligand in the equatorial plane. The geometry is compared with that of previously reported 1:2 uranyl–diphenoxide complexes.     

trans‐μ‐Oxamido‐N,N′‐diethano­ato‐bis­[di­aqua­copper(II)] dihydrate

The title complex, trans‐{μ‐2,2′‐[(1,2‐dioxoethane‐1,2‐diyl)­diimino]­diethano­ato(4−)}bis­[di­aqua­copper(II)] dihydrate, [Cu₂(C₆H₄N₂O₆)(H₂O)₄]·2H₂O, with a three‐dimensional framework, displays a square‐pyramidal coordination geometry. The structure consists of a neutral centrosymmetric binuclear unit in which the ox­amide ligand has a trans geometry, is fully deprotonated and acts in a bis‐tridentate fashion.     

Transition metal complexes with pyrazole‐derived ligands. XI. [Zn(μ‐L)(HL)(OAc)]2 (HL is 4‐acetyl‐3‐amino‐5‐methyl­pyrazole)

The title compound, bis(μ‐4‐acetyl‐3‐amino‐5‐methyl­pyrazol­ato‐N¹:N²)­bis­[(acetato‐O)­(4‐acetyl‐3‐amino‐5‐methyl­pyraz­ole‐N²)­zinc(II)], [Zn₂(C₆H₈N₃O)₂(C₂H₃O₂)₂(C₆H₉N₃O)₂], ex‐ists as a centrosymmetric binuclear mol­ecule with two tetrahedrally coordinated Zn atoms bridged by two pyrazolate anions. The geometry of the terminal and bridging pyrazole ligands are slightly different as a consequence of their differing modes of coordination.     

Complexes of di­methyl­tin dihalides with N‐methyl­pyrrolidinone,C12H24N2O2X2Sn (X = Cl,Br or I)

The single‐crystal X‐ray structure determinations of the title complexes, cis‐di­chloro‐trans‐di­methyl‐cis‐bis(N‐methyl­pyr­rolidin‐2‐one‐O)­tin(IV), [Sn(CH₃)₂Cl₂(C₅H₉NO)₂], cis‐di­bromo‐trans‐di­methyl‐cis‐bis(N‐methyl­pyrrolidin‐2‐one‐O)tin­(IV), [SnBr₂(CH₃)₂(C₅H₉NO)₂], and cis‐di­iodo‐trans‐di­methyl‐cis‐bis(N‐methyl­pyrrolidin‐2‐one‐O)­tin(IV), [Sn(CH₃)₂I₂(C₅H₉NO)₂], show that those tin complexes in which coordination of the lactam ligand to Sn^IV is realized via oxygen exhibit a distorted octahedral geometry.     

cis‐[1,4‐Bis(di­phenyl­phosphino)­butane](μ‐tetra­thio­tungstato)­palladium(II) N,N′‐di­methyl­form­amide hemisolvate hemihydrate

In the title compound, [1,4‐bis(di­phenyl­phosphino)­butane‐2κ²P,P′]­di‐μ‐thio‐1:2κ⁴S‐di­thio‐1κ²S‐palladium(II)­tung­sten(VI) N,N′‐di­methyl­form­amide hemisolvate hemihydrate, [PdWS₄­(C₂₈H₂₈P₂)]·0.5C₃H₇NO·0.5H₂O, the Pd atom is coordinated by two S atoms from the distorted‐tetrahedral [WS₄]²⁻ anion and two P atoms from the dppb mol­ecule [dppb is 1,4‐bis(di­phenyl­phos­phino)­butane] in an approximately square‐planar configuration. A puckered seven‐membered ring is formed by the Pd atom and the dppb ligand.